AVODAGEN supplies qualified business and institutional partners only. Every account undergoes structured verification before pricing, sample material, or commercial terms are shared. This framework protects buyers, sellers, and the integrity of the research peptide supply chain.
Serious B2B research peptide suppliers verify their buyers. This is expected by regulators, required by payment processors and banks, standard among institutional buyers, and essential to maintaining the integrity of research use only positioning. AVODAGEN's verification framework aligns with practices at established research chemical suppliers globally.
Research use only positioning requires reasonable basis to believe buyers use materials for research. Structured verification satisfies this expectation.
Institutional buyers face procurement and compliance review internally. AVODAGEN's verification framework provides documentation supporting their own compliance.
Verified buyers keep research peptide supply chains separated from consumer sales. This benefits legitimate research supply globally.
AVODAGEN qualifies buyers across the legitimate research and pharmaceutical supply landscape. Each category has specific verification requirements matched to the buyer's institutional context.
B2B catalog operators serving institutional research customers. Verification includes business registration, tax identification, industry standing, and downstream customer verification framework.
Pharmaceutical and biotech research organizations. Verification includes corporate registration, research program context, institutional email verification, and end-use certification.
CROs conducting research on behalf of pharmaceutical or biotech clients. Verification includes CRO registration, active research contracts, and institutional standing.
Universities, government research institutes, and academic laboratories. Verification includes institutional email domain (.edu, .ac, or equivalent), principal investigator identification, and departmental affiliation.
US pharmacy compounding operations. Verification includes state licensure, DEA registration where applicable, and 503A/503B facility documentation. Product-specific qualification based on FDA guidance.
Pharmaceutical development organizations, formulation companies, and licensed pharmaceutical operations. Verification includes regulatory standing, development context, and appropriate licensure documentation.
Verification follows a structured four-stage process. Each stage builds trust and documentation progressively. Buyers proceeding through all four stages become fully qualified AVODAGEN accounts with access to catalog, pricing, sample material, and full documentation packages.
Timeline: Immediate upon inquiry submission
Automated screening filters obvious consumer inquiries. Business email domain, commercial address, corporate context, and non-consumer language are baseline requirements. Consumer domain email accounts and residential shipping addresses are not qualified.
Timeline: 24 to 48 hours
Business registration, tax identification, and corporate standing verified against appropriate government or institutional databases. Business address confirmed as commercial. Corporate email domain confirmed as matching the verified entity. Manual review by AVODAGEN compliance.
Timeline: 3 to 7 business days
Research or pharmaceutical use case documented. Intended molecules and applications reviewed against AVODAGEN supply scope. Principal investigator or responsible party identified for academic buyers. Downstream customer verification framework confirmed for B2B resellers. Institutional standing validated.
Timeline: 5 to 10 business days from stage 03 completion
Terms of Supply executed including research-use restrictions, resale limitations, and audit rights. Mutual non-disclosure agreement exchanged. Qualified buyer account activated in AVODAGEN systems. Catalog access, sample analytical certificates, and commercial pricing shared. Account remains subject to annual re-verification and ongoing monitoring.
Documentation requirements vary by buyer category. AVODAGEN requests minimum necessary documentation to complete verification. All documentation is held securely and used exclusively for qualification purposes.
Qualified buyers execute AVODAGEN Terms of Supply as part of account activation. These terms formalize the research-use nature of the supply relationship and establish mutual expectations.
Buyer acknowledges materials are supplied for research use only, are not for human consumption or therapeutic use, and are not approved for clinical or diagnostic applications.
Materials may not be resold to individual consumers. Downstream sales are permitted only to other verified qualified business or institutional buyers with equivalent research-use restrictions.
Buyer confirms appropriate facilities, protocols, and trained personnel to handle research materials safely per applicable regulatory guidance and institutional standards.
Buyer maintains records of receipt, storage, use, and disposition of materials consistent with institutional record-keeping requirements. AVODAGEN reserves right to reasonable audit.
Qualified buyer status reviewed annually. Material changes in business status, use case, or downstream customer base require prompt notification to AVODAGEN.
Terms violations, misuse of materials, or sale to unqualified end users result in immediate account termination and forfeiture of qualified buyer status.
AVODAGEN's verification framework exists to protect legitimate research supply integrity. Inquiries that do not meet qualified buyer standards are rejected. This is a feature of AVODAGEN's operating model, not an oversight.
Personal purchases by individuals for personal use, regardless of stated purpose. AVODAGEN does not sell to individuals under any circumstances.
Inquiries from Gmail, Yahoo, Hotmail, and other consumer email domains without corresponding verified business context.
Requests to ship to residential addresses. All qualified buyer shipments go to verified commercial or institutional addresses.
Business entities whose downstream customers are individual consumers rather than qualified institutional buyers.
Requests for molecules outside AVODAGEN's supply scope including patent-protected compounds, controlled substances, and restricted molecules.
Inquiries without adequate business entity documentation, use case information, or institutional context to complete verification.
Qualified partner access begins with initial inquiry submission through the AVODAGEN partner form. All qualification stages proceed from that starting point.